| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
1 Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, and 2 Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
Address correspondence to Bret H. Goodpaster, PhD, University of Pittsburgh, 3459 Fifth Avenue, MUH N807, Pittsburgh, PA 15213. E-mail: goodpaster{at}dom.pitt.edu
|
A |
|---|
|
|
|---|
Given the strong evidence linking mitochondrial dysfunction with aging, insulin resistance, and type 2 diabetes, it is important to more precisely define specific loci of these defects and, perhaps more important, to determine whether clinical interventions may correct these insufficiencies. Previous studies (911) have demonstrated the presence of two distinct mitochondrial populations within skeletal muscle. Subsarcolemmal (SS) mitochondria reside near the sarcolemma, and intermyofibrillar (IMF) mitochondria are located between the myofibrils. It has been suggested that SS mitochondria provide energy for membrane-related events including cell signaling and substrate and ion transport, and IMF mitochondria supply adenosine triphosphate to contracting myofibrils (12). SS mitochondria generally represent only 25%30% of the total amount of skeletal muscle mitochondria, but appear to be more responsive to increased physical activity in rat muscle (10,13), as well as in young human skeletal muscle (1416). Whether there are improvements in specific mitochondrial subpopulations in older adults with reduced mitochondria content and function has yet to be determined.
These prior observations question whether there are specific populations of mitochondria that may be more responsive to intervention, and moreover, whether improvements are simply due to increased mitochondria content. In the present study we examined the effects of moderate exercise training in older adults on changes in mitochondria content and function located within distinct locations within skeletal muscle.
| METHODS |
|---|
|
|
|---|
Intervention
Participants completed a 12-week exercise training program, which has been previously described in detail for a similar group of older adults (17), and will be summarized briefly. Participants were asked to complete a minimum of four and a maximum of six exercise sessions weekly, with at least three supervised sessions weekly. Most exercise, performed by using treadmills or stationary bicycles, or by walking outdoors, was individually prescribed based on time and intensity and was progressive. For the first 4 weeks, the participants exercised for 30 minutes at a heart rate corresponding to 50%60% of maximal aerobic capacity (VO2max). For the next 4 weeks, they increased exercise time to 40 minutes at the same intensity, and for the last 4 weeks they increased the intensity to
70% of VO2max for at least 40 minutes per session.
Study Protocol
Before and after 12 weeks of exercise, participants had a percutaneous muscle biopsy, a test for physical fitness (VO2max), and a blood sample during fasting conditions to determine markers of insulin resistance (glucose and insulin).
VO2max
Participants performed a graded exercise test on an electronically braked cycle ergometer (SensorMedics Ergoline 800S; Yorba Linda, CA) to determine changes in physical fitness (VO2max). Expired air was collected via open-circuit spirometry (SensorMedics 2900) to determine VO2. Heart rate, blood pressure, and electrocardiogram were recorded prior to, during, and immediately following this test. Heart rateVO2 relationships obtained during this graded exercise test were also used to prescribe intensity during each exercise training session.
Insulin Resistance
To determine the training effects on insulin resistance, we calculated homeostasis model assessment of insulin resistance (HOMA-IR), based on fasting glucose and insulin. Plasma glucose was measured using an automated glucose oxidase reaction (YSI 2300 Glucose Analyzer; Yellow Springs, OH). Serum insulin was determined using commercially available radioimmunoassay kits (Pharmacia, Uppsala, Sweden).
Muscle Biopsies
Percutaneous biopsies of the vastus lateralis were obtained in the General Clinical Research Center (GCRC) on a morning after an overnight fast as described previously in more detail (17,18). Participants were given a standard 10 kcal/kg meal consisting of 50% carbohydrate, 30% fat, and 20% protein the night before the biopsy. Participants were instructed not to perform physical exercise 48 hours before the muscle biopsy procedure to help prevent acute effects of exercise on muscle mitochondrial function. Muscle specimens were trimmed, frozen in liquid nitrogen, and stored at 80°C. Baseline and postintervention biopsy specimens from each participant were prepared and analyzed together to avoid any interassay variability in isolation of mitochondria or biochemical analysis.
Preparation of Mitochondrial Fractions
A portion of muscle biopsy samples of (
1015 mg wet weight) were homogenized in ice-cold basic medium (100 mM mannitol, 80 mM gluconateK; 20 mM potassium fluoride, 1 mM MgCl2, 0.2 mM EGTA, 10 mM histidine, 10 mM glucose, 10 mM triethylamine-morpholino-hydroxypropanesulfonic acid (TEA-MOPSO), pH 7.6 at 21°C) containing bovine serum albumin at 5.0 mg/ml, 100 µM deferoxamine mesylate, and antiprotease cocktail III, using a Polytron homogenizer according to the procedures described by Krieger and colleagues (10). All procedures were performed at 4°C. Soluble and particulate fractions were prepared as previously described (19), by centrifugation (45,000 g for 20 minutes), to pellet a particulate (SS + IMF mitochondria) fraction containing >95% of tissue mitochondria. SS and IMF mitochondrial fractions were prepared as described earlier (20). SS mitochondria were isolated from skeletal muscle following gentle extraction procedures, and after the subsequent extraction of myosin, IMF mitochondrial fraction was collected in two subfractions, a free fraction (IMF1) and another fraction more tightly bound to myofibrils (IMF2). Mitochondrial preparations were suspended in 500 µl of medium, containing 0.5 mM EGTA, 0.1 mg/ml bovine serum albumin, 25 mM potassium phosphate buffer, pH 7.0 at 21°C, and were kept at 80°C until assay.
Mitochondrial DNA Determinations
DNA (mitochondrial and nuclear) was extracted from tissue samples using a QIAamp DNA Mini Kit (QIAGEN, Chatsworth, CA). The concentration of each sample was determined using a GeneQuant spectrophotometer (Pharmacia Biotech). Mitochondrial DNA (mtDNA) content was measured using real-time polymerase chain reaction (PCR) as described earlier (20,21). Detection of a 69 bp fragment of mtDNA (nucleotides 1491814986) and a 77 bp fragment of ß-globin, both based on markers published by Miller and colleagues (22), were used to determine relative copy number of mtDNA per diploid nuclear genome. Primers and 6-carboxyfluorescein (FAM)-labeled Taqman 6-carboxy-tetramethyl-rhodamine (TAMRA) probes (450025; Applied Biosystems, Foster City, CA) were designed using Primer Express software, version 1.5 (Applied Biosystems). Detection of mtDNA and ß-globin was performed as two separate reactions, but within the same run for each sample. All samples were run in duplicate for each gene. Reactions were carried out in the presence of 1X Taqman Universal PCR Master Mix (4304437; Applied Biosystems), 1 µM each forward and reverse primer, 0.25 µM (FAM) labeled Taqman/TAMRA probe, and 20 ng of sample DNA to a final volume of 25 µl. Amplification reactions were performed in an ABI Prism 7700 spectrofluorometric thermal cycler (Applied Biosystems) with the following cycle conditions: 50°C for 2 minutes of uracil-DNA-glycosylase (UNG) incubation, 95°C denaturation and enzyme activation step for 10 minutes followed by 40 cycles of 95°C denaturation for 15 seconds, and 60°C annealing and elongation for 60 seconds. Fluorescence spectra were recorded during the annealing phase of each PCR cycle. The Sequence Detection System software (SDS v1.7) of the ABI-Prism 7700 was used to generate the FAM fluorescence.
Threshold Cycle Calculations
The threshold cycle number (Ct) was calculated using SDS software v1.7 and an automatic setting of the baseline. The baseline value was the average fluorescence value of PCR cycles 315 plus 10 times its standard deviation. These values were used for the relative copy number (Rc) calculations by expressing Ct differences of the ß-globin and mtDNA PCR as described earlier (21):
|
|
Cardiolipin
Cardiolipin is a phospholipid specific to mitochondria, thus reflecting mitochondria content. Cardiolipin was quantified in each mitochondrial subfraction of previously frozen skeletal muscle biopsies by high performance liquid chromatography (HPLC) analysis of a fluorescence-labeled derivative of cardiolipin (23). Cardiolipin content was normalized to the amount of creatine kinase (CK) activity as the amount of active skeletal muscle.
Electron Transport Chain Activity
Activity of NADH oxidase (rotenone-sensitive NADH:O2 oxidoreductase) was determined in total mitochondria fractions by an HPLC-based assay, as described previously to represent total (complexes IIV) electron transport chain (ETC) activity (24,25). Succinate oxidase (succinate:O2 oxidoreductase) activity was measured in total mitochondria fractions and separately in each SS, IMF1, and IMF2 mitochondrial subfraction according to the separation scheme outlined above. Succinate oxidase is a reaction starting from succinate dehydrogenase (SDH; complex II), and is based on assay of the accumulation of fumarate, the end-product of succinate oxidation as described earlier (20,25). This procedure is a modification of a previously developed assay (7,26). Briefly, the assay couples fumarase and malic dehydrogenase reactions to oxidize fumarate and reduce NAD+, with HPLC and fluorescence detection used to measure NADH (19,25). Activity of CK was measured an index of muscle fiber content in biopsy samples as previously described (7,20,25), and ETC activity is expressed normalized to CK activity.
Statistics
Data are presented as mean ± standard error of the mean, unless otherwise indicated. Paired t tests were used to determine effects of exercise intervention on changes in mitochondria content, ETC activity, physical fitness, and markers of insulin resistance. Two-way analysis of variance was used to compare subfractions of mitochondria and their differential response over time (mitochondrial subfraction x time).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
65%), whereas the SS fraction contained a much smaller proportion of cardiolipin (
14%). Following intervention, there was a highly significant increase in cardiolipin content in the IMF2 and SS fractions, and the relative proportion of cardiolipin content among the three remained essentially unchanged.
|
| DISCUSSION |
|---|
|
|
|---|
One of the classic responses to exercise is an increase in the oxidative capacity of skeletal muscle (2729). Relatively few of the many human studies of exercise intervention, however, have focused on elderly persons. A few earlier studies have demonstrated that chronic endurance training increased the amount of mitochondrial protein (30) and mitochondrial volume (31) in skeletal muscle of older men and women concomitant with enhanced overall physical fitness. In the current study, we have expanded upon this important earlier work by broadening the scope of biochemical assessments of mitochondrial content and function in response to increased physical activity in older men and women.
Although the response observed in the participants of the current study was quite positive, it was not clear that this would in fact occur. Many age-related declines in physiological function can be partially attributed to mitochondrial dysfunction (32,33). There is a significant loss in the number of muscle fibers and also biochemical and morphological abnormalities in aging skeletal muscle (34,35). The specific mechanisms leading to the age-related changes are currently unknown. Mitochondria are primary sites of reactive oxygen species formation that cause progressive damage to mtDNA and proteins (35,36). The analysis of human muscle mitochondria has revealed a progressive decline in mitochondrial respiratory chain function with age (1,3,37,38), which may be related to reduced mtDNA content (3). These studies collectively raise the question of whether age-related mitochondrial defects are the result of normal aging or, conversely, whether they are at least partially acquired through lifestyle and factors other than aging per se.
An important area for investigation is to more fully evaluate whether aging limits or alters the response of mitochondria to intervention. Previously, our laboratory (7,20) has observed an impaired bioenergetic capacity of skeletal muscle mitochondria in type 2 diabetes and obesity, including smaller mitochondria and reduced ETC activity (7). The ETC activity in the healthy older participants in this study at baseline was 3-fold less than that observed in younger lean individuals, but similar to that seen in middle-aged obese participants without type 2 diabetes (20). In particular, the lower ETC activity in these older men and women was pronounced in SS mitochondria compared to IMF mitochondria; there was an approximately 4-fold lower succinate oxidase activity in the SS mitochondria in these elderly participants in comparison with lean younger individuals (24). Similarly, Ritov and colleagues (20) reported a greater deficiency in the SS mitochondria in persons with type 2 diabetes and obesity. In contrast, the ETC activity in skeletal muscle of younger individuals was distributed evenly across the fractions, with approximately one third of overall activity in the SS fraction compared to 21% in these older adults (20). This finding suggests that there may be age-related reductions in oxidative capacity of muscle and, specifically, deficiencies in certain mitochondrial subpopulations in aging. Alternatively, mitochondrial subpopulations could be affected differently by physical activity related to aging. Although the response of these generally healthy older volunteers was quite robust, the limited sample size of our study prevents us from generalizing these results to older persons who may have functional impairments, more severe insulin resistance, or type 2 diabetes.
Few studies have examined whether improvements in mitochondrial function and/or content are related to the improvements in insulin resistance and risk for the development of metabolic syndrome or type 2 diabetes. HOMA-IR as a marker of insulin sensitivity (39) improved in parallel with improved mitochondria content and function. These results are consistent with the observations that higher oxidative capacity is related to higher insulin sensitivity (40), and that an exercise-enhanced reliance on fat oxidation predicts improved insulin sensitivity in obese (41) and in elderly (42) persons. These results, however, are in apparent contrast to the study by Short and colleagues (43), who reported increased oxidative capacity in older men and women despite little improvement in insulin sensitivity. Thus, the relationship between increased mitochondrial function and insulin resistance should be examined further.
To our knowledge, this is the first study examining the effects of exercise on the function of distinct mitochondrial subpopulations within aging skeletal muscle. The increase in ETC activity of complex IIIV (succinate oxidase) was more pronounced in SS mitochondria than in IMF mitochondria. The total ETC assessed by NADH oxidase activity, as well as total succinate oxidase activity, paralleled the increase in total mitochondria content measured as mtDNA content and cardiolipin, all increasing by more than 50%. The degree of response in cardiolipin within the SS and IMF mitochondrial subfraction was closely matched to the increases in ETC within the same fraction. Moreover, the ratio of ETC activity to mitochondria content (cardiolipin) did not change with intervention. Higher mitochondria content in young endurance-trained individuals compared to untrained participants was more prominent for the SS mitochondrial population than for the IMF population (29). Chilibeck and colleagues (15) reported that endurance training resulted in greater increases in SS SDH activity compared to IMF mitochondria. However, Krieger and colleagues (10) reported similar increases in SDH activities in the SS and IMF mitochondrial populations of rat skeletal muscle in response to chronic endurance training. SS mitochondria likely provide energy for cellular processes of substrate transport and cell signaling in skeletal muscle (12), and exhibit higher rates of fatty acid oxidation (44). Thus, SS mitochondria may be specifically linked to physical inactivity, low oxidative capacity, and insulin resistance. Further inquiry into the functional significance of how different mitochondrial subpopulations in human skeletal muscle respond to various interventions might provide insight into mitochondria as potential therapeutic targets for prevention and treatment of insulin resistance and type 2 diabetes.
Summary
Mitochondrial function, as assessed by ETC activity, and content of mitochondria improved similarly with exercise training. However, there were distinct differences in the response of ETC activity within specific populations of skeletal muscle mitochondria. Additional studies are clearly needed to determine the specific function of these mitochondrial subpopulations and, further, to investigate whether there are specific components of mitochondrial function that are implicated in age-associated and obesity-associated disorders. These findings could have implications for designing specific interventions, including exercise, in the treatment and prevention of skeletal muscle functional changes with aging.
|
A |
|---|
|
|
|---|
We greatly appreciate the nursing staff of the University of Pittsburgh General Clinical Research Center and also Andreas Katsiaras and Donna Wolf for their efforts in carrying out the exercise intervention. We express our appreciation to the research volunteers who participated in these studies.
|
F |
|---|
|
|
|---|
Received October 10, 2005
Accepted December 13, 2005
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Rao, L. Li, C. Demello, D. Guo, B. L. Jaber, B. J.G. Pereira, V. S. Balakrishnan, and the HEMO Study Group Mitochondrial DNA Injury and Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., January 1, 2009; 20(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Lanza, D. K. Short, K. R. Short, S. Raghavakaimal, R. Basu, M. J. Joyner, J. P. McConnell, and K. S. Nair Endurance Exercise as a Countermeasure for Aging Diabetes, November 1, 2008; 57(11): 2933 - 2942. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Marcus, S. Smith, G. Morrell, O. Addison, L. E Dibble, D. Wahoff-Stice, and P. C LaStayo Comparison of Combined Aerobic and High-Force Eccentric Resistance Exercise With Aerobic Exercise Only for People With Type 2 Diabetes Mellitus Physical Therapy, November 1, 2008; 88(11): 1345 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Amati, J. J. Dube, C. Shay, and B. H. Goodpaster Separate and combined effects of exercise training and weight loss on exercise efficiency and substrate oxidation J Appl Physiol, September 1, 2008; 105(3): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Dube, F. Amati, M. Stefanovic-Racic, F. G. S. Toledo, S. E. Sauers, and B. H. Goodpaster Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E882 - E888. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.S. Toledo, E. V. Menshikova, K. Azuma, Z. Radikova, C. A. Kelley, V. B. Ritov, and D. E. Kelley Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content Diabetes, April 1, 2008; 57(4): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.S. Toledo, E. V. Menshikova, V. B. Ritov, K. Azuma, Z. Radikova, J. DeLany, and D. E. Kelley Effects of Physical Activity and Weight Loss on Skeletal Muscle Mitochondria and Relationship With Glucose Control in Type 2 Diabetes Diabetes, August 1, 2007; 56(8): 2142 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Menshikova, V. B. Ritov, R. E. Ferrell, K. Azuma, B. H. Goodpaster, and D. E. Kelley Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity J Appl Physiol, July 1, 2007; 103(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Heilbronn, S. K. Gan, N. Turner, L. V. Campbell, and D. J. Chisholm Markers of Mitochondrial Biogenesis and Metabolism Are Lower in Overweight and Obese Insulin-Resistant Subjects J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P Corcoran, S. Lamon-Fava, and R. A Fielding Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise Am. J. Clinical Nutrition, March 1, 2007; 85(3): 662 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Chow, L. J. Greenlund, Y. W. Asmann, K. R. Short, S. K. McCrady, J. A. Levine, and K. S. Nair Impact of endurance training on murine spontaneous activity, muscle mitochondrial DNA abundance, gene transcripts, and function J Appl Physiol, March 1, 2007; 102(3): 1078 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ventura-Clapier, B. Mettauer, and X. Bigard Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure Cardiovasc Res, January 1, 2007; 73(1): 10 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferrucci and E. M. Simonsick A Little Exercise J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2006; 61(11): 1154 - 1156. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|